4:35 PM
 | 
Jan 04, 2013
 |  BC Extra  |  Financial News

Synageva raises $102.2 million

Synageva BioPharma Corp. (NASDAQ:GEVA) raised $102.2 million through the sale of 2.2 million shares at $47.53 in a bumped-up follow-on underwritten by Morgan Stanley; JPMorgan; Cowen; Canaccord;...

Read the full 117 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >